Pricing Log in Create free account

Alkermes plc (ALKS) vs Viatris Inc. (VTRS)

Alkermes plc and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Viatris Inc. is the larger, with a market value of $21.8B against $7.5B — 2.9× the size. Alkermes plc grew revenue faster over the last twelve months: 15.3% against 4.27%. Alkermes plc has the higher net margin (−0.02% vs −4.13%) and the higher return on invested capital (1.54% vs −0.02%). Across the 20 metrics below, Alkermes plc leads on 12 and Viatris Inc. on 8.

Valuation

Metric ALKS VTRS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 4.27 1.49 2.08
P/B 4.02 1.61 1.79
Price to free cash flow 32.78 10.69 16.29
EV/EBITDA 37.88 12.34 12.22
EV/Sales 4.69 2.28 2.87
Earnings yield 0.00% (2.81%) (15.94%)
Free cash flow yield 3.05% 9.35% 0.00%

Profitability

Metric ALKS VTRS Drug Manufacturers Specialty & Generic median
Gross margin 82.89% 35.31% 53.51%
Operating margin 3.66% (0.03%) 0.00%
Net margin (0.02%) (4.13%) (2.45%)
Free cash flow margin 13.03% 16.27% 0.00%
Return on equity (0.02%) (4.21%) (0.80%)
Return on assets (0.01%) (1.67%) (1.67%)
Return on invested capital 1.54% (0.02%) 0.00%

Growth

Metric ALKS VTRS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 15.27% 4.27% 5.22%
EPS growth (last fiscal year) (34.10%) (466.04%) 42.91%
Revenue growth, 5-year CAGR 7.28% 3.66% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALKS VTRS Drug Manufacturers Specialty & Generic median
Debt to equity 0.80 0.13 0.04
Current ratio 2.42 1.55 2.41
Net debt to EBITDA (4.69) 4.92 1.01

Dividend

Metric ALKS VTRS Drug Manufacturers Specialty & Generic median
Dividend yield — 2.54% 1.45%
Payout ratio — — 0.27

Size

Metric ALKS VTRS Drug Manufacturers Specialty & Generic median
Market cap 7.48b 21.79b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack